Institutions in Colorado received $592.4M in NIH funding in fiscal year 2026 across 1,259 awards, #19 among states. University of Colorado Denver received the most, $397.9M, and the NIA was the largest funding institute.
| Rank | Institution | Awards | NIH funding |
|---|---|---|---|
| 1 | University of Colorado Denver | 823 | $397.9M |
| 2 | University of Colorado | 158 | $67.8M |
| 3 | Colorado State University | 139 | $61.0M |
| 4 | National Jewish Health | 41 | $27.7M |
| 5 | University of Denver (colorado Seminary) | 24 | $8.1M |
| 6 | Allander Biotechnologies, Inc. | 2 | $2.3M |
| 7 | Denver Health and Hospital Authority | 4 | $1.8M |
| 8 | Colorado School of Mines | 6 | $1.8M |
| 9 | Modendo Inc. | 1 | $1.5M |
| 10 | Intero Biosystems Inc. | 2 | $1.4M |
| 11 | Klein Buendel, Inc. | 2 | $1.3M |
| 12 | Quspin | 1 | $1.3M |
| 13 | Wavi Company | 1 | $1.2M |
| 14 | Numiera Therapeutics Inc | 1 | $1.2M |
| 15 | Edify | 1 | $1.1M |
| 16 | Pathware Inc. | 1 | $1.1M |
| 17 | Meadowlark Optics, Inc. | 1 | $1.0M |
| 18 | Commonspirit Health Research Institute | 1 | $1.0M |
| 19 | Peak Diagnostic Partners Llc | 1 | $1.0M |
| 20 | Double Helix Optics Inc. | 1 | $976K |
| 21 | Hydronovo, Inc | 1 | $882K |
| 22 | Onconaut Therapeutics Inc. | 1 | $760K |
| 23 | Neurexis Therapeutics, Inc. | 2 | $723K |
| 24 | Op-T-Mune, Inc. | 1 | $635K |
| 25 | Exovista Llc | 1 | $458K |
| Institute | Focus | Funding |
|---|---|---|
| NIA | aging and Alzheimer's disease | $77.3M |
| NIAID | infectious disease, immunology and allergy | $76.2M |
| NHLBI | heart, lung, blood and sleep | $64.9M |
| NIGMS | basic biomedical science and research training | $57.1M |
| NCI | cancer | $54.7M |
| NIDDK | diabetes, digestive and kidney disease | $50.0M |
| NICHD | child health, pregnancy and development | $45.5M |
| NINDS | neurology and stroke | $33.2M |
| NIDA | addiction and substance use | $27.6M |
| NIMH | mental health | $18.2M |
NIH awards to Colorado institutions moved from $585.7M in fiscal year 2025 to $592.4M in 2026, a change of +1.1% against -0.3% nationally.
| Institution | FY2025 | FY2026 | Change |
|---|---|---|---|
| Colorado School of Mines | $5.0M | $1.8M | -65.2% |
| Klein Buendel, Inc. | $3.8M | $1.3M | -65.0% |
| Colorado State University | $63.4M | $61.0M | -3.9% |
| Neurexis Therapeutics, Inc. | $2.1M | $723K | -66.1% |
| Dream Face Technologies, Llc | $1.4M | $314K | -78.0% |
| University of Colorado Denver | $387.1M | $397.9M | +2.8% |
| National Jewish Health | $23.8M | $27.7M | +16.3% |
| University of Colorado | $65.3M | $67.8M | +3.7% |
| Intero Biosystems Inc. | $350K | $1.4M | +299.1% |
| Allander Biotechnologies, Inc. | $1.2M | $2.3M | +84.5% |
Largest decreases first, then largest increases. Every state compared.
See Colorado university research spending (all sources, NSF HERD) and every federal funder.
Colorado is #19 on NIH funding by state.